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Abstract 
 
ObjectivePuberty is a critical time in the development of overweight and obesity. The aim of 
this study was to examine relationships between measures of adiposity, cardiovascular 
fitness, and biomarkers of cardiovascular disease risk in adolescents. 
Methods 
In a cross-sectional study design, 129 girls and 95 boys aged 12.9–14.4 years at various stages 
of puberty were included, along with their mothers (n = 217) and fathers (n = 207). 
Anthropometric assessments of adiposity were made, along with cardiovascular physical 
fitness, using the 20-m shuttle-run test, and biomarkers associated with cardiovascular risk, 
including glucose, insulin, triglyceride, fibrinogen, and C-reactive protein concentrations. 
Results 
Waist-to-height ratio (WHtR) values were similar in boys and girls and correlated positively 
with glucose, insulin, triglyceride, fibrinogen, and C-reactive protein concentrations, and 
inversely with cardiovascular fitness scores. Skinfold-thickness (SKF) measurements were 
higher in girls. high molecular weight (HMW)-adiponectin concentrations were lower in boys 
compared to girls, particularly in late puberty, and C-reactive protein levels were higher. 
Cardiovascular fitness, maternal body mass index (BMI), and paternal BMI contributed 
independently to the variance in waist measurements in girls and boys. Gender, triceps SKF, 
and WHtR, but not parental BMI, contributed independently to the variance in cardiovascular 
fitness. 
Conclusion 
There is a relationship between measures of adolescent adiposity and parental weight that 
involves factors other than cardiovascular fitness. Adolescent boys have relatively more 
abdominal fat than girls and a tendency to have a proinflammatory profile of biomarkers. 
These observations suggest that family and social environmental interventions are best 
undertaken earlier in childhood, particularly among boys. 
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1. Introduction 
Childhood obesity predicts obesity later in adulthood1 and is associated with adult 
cardiovascular disease and related mortality.2 Increasing prevalence of obesity in childhood 
is therefore likely to have pathophysiological consequences and translate to an increased 
incidence of cardiovascular events in adulthood.3 It is now recognized that there is an 
interaction between overweight and fitness that contributes to cardiovascular risk and 
prognosis.4 Adolescence is associated with increases in overweight and obesity5 and a 
reduction in levels of physical activity.6 Puberty is therefore a stage when promotion of 
healthy behaviors may be crucial. Family environment is likely to play an important role; for 
example, an overweight mother and a single-parent family are associated with an increased 
likelihood of a child being overweight or obese.7  
In adolescence, calculation of body mass index (BMI) does not fully adjust for the 
effect of height.8,9 The waist-to-height ratio (WHtR) is regarded as a better marker of 
adiposity10 and may be a stronger predictor of cardiovascular disease risk factors.11 Rising 
adiposity in childhood, however, is not necessarily accompanied by deteriorating metabolic 
profile.12 It is likely that a combination of adiposity measures and proinflammatory markers 
is a better predictor than measurement of adiposity alone.13 There is an effect of gender on 
these measures; for example it is reported that high-sensitivity C-reactive protein (hsCRP) 
concentrations are higher in girls.14 
The aim of this study was to examine the effect of gender and puberty on the 
relationship between measures of adiposity and cardiovascular fitness and (i) inflammatory 
and metabolic biomarkers known to be associated with disease risk in adults, including serum 
CRP, insulin and lipid concentrations and (ii) parental BMI and waist circumference. We have 
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previously shown that aerobic fitness, estimated with a 20-metre shuttle-run test, is inversely 
related to measures of adiposity in adolescent boys and girls with no significant effect of 
pubertal status on the relationship.8 It was hypothesised that in this group of adolescents 
those with greater adiposity and lower cardiovascular fitness are more likely to have a 
biomarker profile that is associated with increased cardiovascular risk. Furthermore, it was 
hypothesised that an increased cardiovascular risk profile is more likely in boys and in children 
whose parents are overweight or obese. 
2. Methods 
2.1 Participants 
In a cross-sectional study of children in Year 8 (age range 12.9 –14.4 years) in 3 schools 
in Carmarthenshire, Wales,15 information letters were sent to parents and guardians of 
potential participants. The response rate was 86%. The number of children registered as 
receiving free school meals was lower than the national average (1% vs. 16%),15 and was 
similar in all 3 schools, indicating similar socioeconomic status.16 Signed consent was obtained 
from parents or guardians and children. The study was conducted in accordance with the 
Declaration of Helsinki and approved by the local National Health Service Research Ethics 
Committee (Dyfed Powys; 07/WMW01/12). 
Data on self-assessed pubertal status, along with measurements of weight, waist, 
height, and skinfold thickness (SKF) were available from 247 participants. The relationship 
between weight, waist, height, and cardiovascular fitness measurements in that group were 
presented in a previous publication.8 For inclusion in the present study, those that had a 
measure of cardiovascular fitness and blood analysis that included insulin concentration, and 
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were selected. A total of 224 participants (129 girls and 95 boys) met the inclusion criteria. 
Weight, waist, height, and SKF measurements for this group were similar to the larger cohort 
(data not shown). 
2.2 Physical measurements 
All measurements were carried out by the same researcher, an experienced paediatric 
exercise physiologist. Children wore light clothing and were barefoot. Privacy was assured 
and two gender-specific adults were present at all times. Body height was measured using a 
portable stadiometer (Holtain Ltd, Crymych, Pembrokeshire, UK) and weight was measured 
using a calibrated Philips HP 5320 electronic scale (Philips N.V., Amsterdam, The 
Netherlands). Waist circumference was measured, directly over the skin, at the smallest 
circumference between the lower costal margin and iliac crest using anthropometric tape 
(Holtain Ltd). Waist is also reported as a percentage of height (WHtR%) when appropriate. 
SKF measurements were made at the triceps, biceps, subscapular, and suprailiac sites on the 
right side using Harpenden skin-fold callipers (Holtain Ltd, Brynberian, UK) and standard 
techniques. Anthropometric measurements were made in duplicate and if the values differed 
by greater than 1.0 mm or 0.1kg, a third measurement was taken. The intra-observer 
technical error of measurement (TEM)16 was determined in a study of 20 measurements. The 
TEM was < 1.0 mm (coefficient of reliability [R] > 0.99) for height measurement. The TEM for 
waist was 0.98 mm (R = 0.973), and TEMs for SKF were 0.42 mm (R = 0.996), 0.42 mm (R = 
0.989), 0.51 mm (R = 0.993), and 0.54 mm (R = 0.992), respectively, for triceps, biceps, 
subscapular, and suprailiac sites. Systolic and diastolic blood pressure was taken 3 times, after 
the child had been sitting quietly for 5 min (Dinamap IL, Critikron, Inc., Tampa, FL). The 
average of the second and third readings was recorded. 
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Parents were asked to complete a form reporting the child’s birth-weight, as well as 
their own date of birth and adult height, weight, and waist measurements. Parental self-
reported height and weight and/or waist measurements were available from parents of 218 
of the 224 children: 217 mothers (mean age 41.7 years, 95% confidence interval (CI) [41.0-
42.3 years]) and 207 fathers (mean age 44.0 years [95% CI 43.2–44.9 years]). Maternal BMI, 
calculated from self-reported weight and height, was 26.6 kg/m2 (95% CI 25.9–27.3 kg/m2, n 
= 209) and paternal BMI was 28.0 kg/m2 (95% CI 27.5–28.6 kg/m2, n = 196). Since self-reported 
height tends to be overestimated and weight underestimated, published equations were 
used to adjust parental BMI values.17 The formula used for the mother’s value was BMIcorrected 
= 0.12 + 1.05XBMIself-reported, and for the father’s it was BMIcorrected = 0.12 + 1.05XBMIself-reported. 
Corrected maternal BMI was 27.8 kg/m2 (95% CI 27.1–28.5 kg/m2), and corrected paternal 
BMI was 29.2 kg/m2 (95% CI 28.6-29.8 kg/m2). 
2.3 Pubertal assessment 
Pubertal status was determined with self-assessment questionnaires using gender-
specific line drawings of the stages18 based on those described by Tanner.19 Children 
completed the questionnaire alone and in private at home. Within each gender group, those 
reporting being in stages 1–3 (T1–3) and in stages 4–5 (T4–5), were combined for data 
analysis.8 All children reporting being in stage 1(T1) for breast or genital development 
reported being in stages 2–4(T2–4) for pubic hair development (Table I). Status assessed by 
breast development or genital development was used for the correlations. Similar patterns 
were observed in correlations using pubic hair development. Since stages of pubertal 
development are not equivalent, analyses were performed separately for boys and girls. 
2.4 Cardiovascular fitness 
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A 20-m shuttle-run test was used as an indirect measurement of maximal aerobic 
power.20 Participants ran between 2 parallel lines 20 metres apart. A commercially available 
audio tape that emits a beep at the point where the runner should be pivoting at the next line 
was used. The pacer started at 8.5 km/h and increased by 8.5 km/h each minute and was 
timed for accuracy before each session. Boys and girls performed separately. Testing took 
place at the same time of day, supervised by a person trained in the method, who gave 
consistent verbal encouragement. All participants were fully familiarised with testing 
procedures prior to data collection. The test ended if running could not be maintained 2 laps 
in succession, or voluntarily if the participant was exhausted. The number of laps completed 
was used as the cardiovascular fitness score. 
2.5 Biomarkers 
Serum was prepared from blood samples collected between 9 am and 12 noon 
following an overnight fast and after the child had been sitting at least 30 min. Glucose was 
determined by the glucose oxidase method (Randox Laboratories LTD, Crumlin, CO Antrim, 
UK). Total cholesterol and triglyceride concentrations were determined by routine enzymatic 
techniques (Vitros 950 System, Ortho-Clinical Diagnostics, Amersham, Bucks, UK). Laboratory 
analytical variances were 1.5%, 1.6%, and 2%, respectively, for the above 3measurements. 
High density lipoprotein (HDL)-cholesterol was determined after precipitation of very-low-
density and low-density lipoproteins (LDLs) with dextran sulphate and magnesium chloride 
(coefficient of variation (CV) 5.3%). LDL-C concentrations were estimated by the Friedwald 
formula. Insulin concentration was determined using an enzyme-linked immunosorbent assay 
(ALPCO Diagnostics, Salem, NH; CV 7.5%). Interleukin 6 (IL-6) and high molecular weight 
(HMW)-adiponectin were measured using enzyme-linked immunosorbent assay kits from 
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R&D Systems (Abingdon, UK; CV 8.9% and 8.4%, respectively). Concentrations of hsCRP were 
measured using latex-enhanced immunoturbimetric assay (Randox Laboratories) on a Cobas 
FARA bioanalyser (Roche Products Ltd, Herts UK; lower detection limit 0.1 mg/l, CV 5.5%). 
Fibrinogen was determined using an automated coagulation analyzer (ACL Futura; 
Instrumentation Laboratory Company, Lexington, MA; CV 1.6%). 
2.6 Statistics 
Data were tested for normality by examining histograms of values and using the 
normality plot, Skewness value, and Shapiro-Wilk test. Waist, SKF, and biochemical variables 
were not normally distributed and were normalized by log-transformation before analysis 
and are presented as geometric means. The homeostatic model assessment (HOMA) index 
was calculated using insulinXglucose/22.5.21 
Sex differences were analysed by independent (unpaired) Student’s t tests. Effects of 
sex and puberty, or sex and waist measurement, were analysed by two-way analysis of 
variance (ANOVA). Log-log regression analysis was used to estimate the power with which to 
raise the height to correct SKF measurements.8,23 Pearson correlation coefficients were 
calculated between pairs of variables. Linear and non-linear regression analyses were used, 
as appropriate, to determine the relationship between variables. Hierarchical multiple 
regression analysis was used to identify independent predictor variables, after ensuring no 
violation of the assumptions of normality, linearity, multicollinearity, and homoscedasticity. 
Since patterns differed by gender, the gender were also considered separately. Statistical 
analyses were performed using SPSS Statistics Version 20 (IBM Corp., Armonk, NY, USA) and 
Statistica Version 10 (StatSoft Inc., Tulsa, OK, USA). To take into account multiple 
measurements, the level of statistical significance was determined using the Bonferroni 
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correction. Uncorrected p-values are shown. A level of significance of p < 0.05 was set for 
multiple regression.  
 
3. Results 
3.1 Biomarkers associated with metabolic and cardiovascular risk in girls and boys 
Biomarkers and cardiovascular fitness measurements were available from 129 girls 
and 95 boys (Table 2). In this cohort of 13-year-olds, boys had higher cardiovascular fitness 
scores than girls. They also tended to be taller and have higher birth weight. Height in girls 
correlated with birth weight (r = 0.395; p < 0.01, n = 129) but this was not significant in boys 
(r = 0.146; p = 0.17, n = 92), and there was no relationship between birth weight and any other 
measurement, among girls or boys or among their parents (data not shown). Girls had higher 
SKF measurements than boys; however, waist circumference expressed as a percentage of 
height (WHtR%) and the ratio of trunk-to-extremity SKF (T/E SKF) did not differ between 
genders. The small difference in age between T1–3 compared to T4–5 was statistically 
significant in girls and not in boys (P = 0.016, Table 3). 
There was a relationship between height and the sum of the skinfold thicknesses 
(4SKF) in children in T1–3 (r = 0.279, p = 0.017, n = 73 for girls, and r = 0.563, p < 0.001, n = 
42, for boys), but not in T4–5 (r = 0.078, p = 0.570, n = 56 for girls, and r = -0.156, p = 0.265, n 
= 53 for boys). Since 4SKF is dependent on height, the relationship between height and each 
SKF was also determined. Gradients obtained from log-log linear regression analysis of height 
and SKF, shown in Table3, indicate that most of the effect of puberty on the relationship 
between height and 4SKF was from the contribution of subscapular SKF and suprailiac SKF 
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measurements. This was markedly apparent in T1–3 boys. There was no significant 
relationship between triceps SKF and height in any group. There was a positive relationship 
between T/E SKF and height in girls in T1–3 and in boys in T1–3 and T4–5. 
There was a similar relationship between WHtR and triceps SKF or T/E SKF irrespective 
of gender or pubertal status (Fig. 1). Non-linear regression lines and correlations did not differ 
significantly in slope; however, in boys with triceps SKF ≥ 10 mm, the mean deviation of the 
WHtR was 7.5% (6.3%–8.6%) above the girls’ curvilinear regression line (p < 0.001). The 
regression lines in girls and boys crossed a WHtR of 44% at triceps SKF measurements of 23 
mm and 16.5 mm, respectively (i.e., values were 42% higher in girls), while the regression 
lines crossed a WHtR of 44% at similar T/E SKF measurements in girls and boys. 
Serum insulin concentrations were higher in girls than in boys (Table2) and correlated 
positively with WHtR in girls and boys (Fig. 2), regardless of pubertal status(data not shown). 
Glucose levels were lower in girls than in boys, and correlated positively with insulin (r = 0.235, 
p = 0.008, n = 126 for girls and r = 0.398, p < 0.001, n = 93 for boys). In boys, insulin 
concentrations correlated with height z scores (r = 0.451, p < 0.001, n = 95 for boys; r = 0.119, 
p = 0.181, n = 129 for girls). In hierarchical multiple regression analysis, glucose and WHtR 
were entered at Step 1 and explained 11% of the variance in insulin. After entry of gender 
and  cardiovascular fitness at Step 2, the total variance in insulin explained by the model was 
34%, F(4,214) = 27.70, p < 0.001. Gender and cardiovascular fitness explained an additional 
23% of the variance in insulin after controlling for glucose and WHtR, F change (2, 214) = 
38.15, p < 0.001. In the final model, the following were statistically significant: glucose (β = 
0.29, p < 0.001), WHtR (β = 0.26, p < 0.001) and gender (β = 0.45, p < 0.001). 
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Serum concentrations of triglyceride and total cholesterol were higher in girls 
(Table2), regardless of pubertal status (data not shown). Fibrinogen and triglyceride 
concentrations, and diastolic blood pressure levels, each correlated positively with WHtR in 
boys and girls, while HDL cholesterol was inversely correlated (Fig. 2). 
HMW-adiponectin concentrations were lower in boys (Table 2) and were lower in late 
puberty (ANOVA F(3,217)=8.201; gender p < 0.001 and puberty p = 0.012; interaction p = 
0.138). Concentrations of HMW-adiponectin were 2.52 mg/l (95%CI 2.09-3.04 mg/l) in the 42 
T1–3 boys and 1.82 mg/l (1.53–2.17 mg/l) in the 52 T4–5 boys. In girls, values were 2.80 mg/l 
(2.36-3.31 mg/l) in the 71 T13 girls and 3.04 mg/l (2.69-3.45 mg/l) in the 56 T4-5 girls(n=56). 
In hierarchical multiple regression analysis, gender and puberty were entered at Step 1 and 
explained 9% of the variance in HMW-adiponectin. After entry of WHtR, insulin and triceps 
SKF at Step 2, the total variance in HMW-adiponectin explained by the model was just 15%, 
F(5,215) = 7.65, p < 0.001. WHtR, insulin and T/E SKF explained an additional 6% of the 
variance in HMW-adiponectin after controlling for gender and puberty, F change (3, 215) = 
4.94, p = 0.002. In the final model, the following were statistically significant: gender (β = 0.30, 
p < 0.001), puberty (β = 0.14, p = 0.032), and T/E SKF (β = -0.15, p = 0.035). 
CRP concentrations were significantly lower in the girls compared to the boys (Table 
2) and correlated with IL-6 (r = 0.360, p < 0.001 in 125 girls and r = 0.466, p < 0.001 in 94 boys). 
There was an association between CRP and WHtR in girls and boys (Fig. 2). In hierarchical 
multiple regression analysis, gender, IL-6 and WHtR were entered at Step 1 and explained 
37% of the variance in CRP. After entry of puberty, insulin, T/E SKF and cardiovascular fitness 
at Step 2, the total variance in CRP explained by the model was 36% F(4,211) = 18.58, p < 
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0.001. In the final model the following were statistically significant: WHtR (β = 0.39, , p < 
0.001), IL-6 (β = 0.29, , p < 0.001) and gender (β = 0.14, p = 0.045).   
3.2 Characteristics of adolescents with higher WHtR 
We compared children with the highest waist circumferences (> 44% of height; 35 girls 
and 26 boys) to the rest of the cohort (94 girls and 69 boys); these results are shown in Table 
4. There were no differences in pubertal status among the 4 groups (data not shown). T/E SKF 
was higher in the group with WHtR >44%, in both girls and boys. Most children with WHtR 
>44% had a triceps SKF measurement of >23 mm in girls and > 16.5 mm in boys (Fig. 1A and 
1C). These children also had higher diastolic blood pressure, insulin concentrations and HOMA 
measurements, and CRP and fibrinogen concentrations, and lower HDL-cholesterol 
concentrations, than the rest of the cohort. The cardiovascular fitness score was lower in girls 
and boys with the higher WHtR. In boys with a WHtR of >44%, there was an inverse correlation 
with insulin concentrations (lnInsulin = 6.251-1.050XlnFitnessScore; r = -0.727, p < 0.001), 
which was not seen in thinner boys or in girls (data not shown). 
3.3 Parental weight and waist measurements 
Parental weight measurements correlated with height (mothers: r = 0.315, P < 0.001; 
fathers: r = 0.381, P < 0.001) and correction of weight by height2 (BMI) removed the effect of 
height. In men, the waist and WHtR correlated with height (r = 0.177, P = 0.014). When the 
formula waist2X10/ht (W2HtR)23 was used, there was no relationship between waist and 
height in mothers or fathers. According to WHO criteria, and using corrected BMI values, 33% 
of mothers were normal weight and 29% were obese (BMI ≥ 30), while 11% of fathers were 
normal weight and 35% were obese. 
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3.4 Relationship between child and parental anthropometric variables 
In the children with WHtR >44%, maternal BMI and W2HtR were higher than for 
mothers of children with a WHtR ≤44% (Table 4). Paternal BMI was also significantly higher. 
Values from children for whom both maternal and paternal BMI were available were included 
in the following analyses (93 girls and 80 boys). 
Correlations between anthropometric variables in children and their parents is shown 
in Table 5. In girls, WHtR correlated significantly with maternal BMI. There was no correlation 
between maternal and paternal BMI; however, there was a significant relationship between 
maternal and paternal W2HtR (data not shown).  
Hierarchical multiple regression analysis was used to determine the impact of parental 
BMI on children’s WHtR, triceps SKF, and T/E SKF. Gender and cardiovascular fitness were 
entered at Step 1 and explained 25% of the variance in child WHtR. After entry of maternal 
and paternal BMI at Step 2, the total variance in child WHtR explained by the model was 33%, 
F(4,184) = 22.22, p < 0.001. Maternal and paternal BMI explained an additional 8% of the 
variance in child WHtR after controlling for gender and cardiovascular fitness, F change (2, 
184) = 10.73, p < 0.001. In the final model, the following independent variables were 
statistically significant: gender (β = 0.31, p < 0.001), cardiovascular fitness (β = -0.49, p < 
0.001), maternal BMI (beta = 0.22, p < 0.001) and paternal BMI (β = .17, p = 0.007). For child 
triceps SKF, gender and cardiovascular fitness, entered at Step 1, explained 32.5% of the 
variance. After entry of maternal and paternal BMI at Step 2, total variance in child triceps 
SKF explained by the model was 37.3%, F(4,184) = 27.38, p < 0.001. Maternal and paternal 
BMI explained an additional 4.8% of the variance, F change (2, 184) = 7.09, p < 0.001. In the 
final model, the following were statistically significant: cardiovascular fitness (β = -0.52, p < 
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0.001) and maternal BMI (β = 0.22, p < 0.001). For child T/E SKF, gender and cardiovascular 
fitness, entered at Step 1, explained 7% of the variance. After entry of maternal and paternal 
BMI at Step 2, total variance in child triceps SKF explained by the model was 14%, F(4,184) = 
7.47, p < 0.001. Maternal and paternal BMI explained an additional 7% of the variance, F 
change (2, 184) = 7.38, p = 0.001. In the final model, the following were statistically significant: 
cardiovascular fitness (β = -0.25, p = 0.001) and paternal BMI (β = 0.22, p = 0.002). 
3.5 Cardiovascular fitness 
We have previously shown that the cardiovascular fitness score is inversely related to 
WHtR and to 4SKF in girls and boys in early/mid and late puberty.8 Since 4SKF is dependent 
on height, we explored the relationship between cardiovascular fitness and triceps SKF. There 
is an inverse relationship, with no difference between those in T1-3 and T4-5 for each gender, 
and with similar combined slopes for girls (fitness score = 107.7-21.82xlnTricepsSKF, r = 0.497, 
p < 0.001, n = 129) and boys (lnWHtR = 3.842-0.287xlnTricepsSKF+0.095xlnTricepsSKF2, r = 
0.752, p < 0.001, n = 95). However the combined regression line was significantly higher for 
boys compared to girls (F(1,221) = 39.477; p < 0.01). In hierarchical multiple regression 
analysis, gender and WHtR were entered at Step 1 and explained 39% of the variance in 
cardiovascular fitness. After entry of maternal and paternal BMI at Step 2, the total variance 
in cardiovascular fitness explained by the model was 39% F(4,184) = 29.58, p < 0.001. In the 
final model the following were statistically significant: gender (β = 0.50, , p < 0.001) and WHtR 
(β = -0.45, p < 0.001),  with no independent contribution of maternal BMI or paternal BMI. 
4. Discussion 
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In this study of adolescents, measures of adiposity correlated with biomarkers that 
are associated with cardiovascular disease risk in adults. Waist and SKF measurements 
correlate with height in children in early or mid-puberty; however, the influence of height is 
lost when waist measurement is expressed as a percentage of height (WHtR). Gender 
differences were observed. Although girls appeared to have more subcutaneous fat and 
reduced levels of cardiovascular fitness, boys had relatively greater central adiposity and 
higher levels of pro-inflammatory markers. Parental overweight and obesity were associated 
with greater adiposity in adolescent girls and boys, suggesting that strategies for reducing 
cardiovascular risk should be family focused. 
The cohort was well controlled for age and socioeconomic status, and we were 
therefore able to estimate the independent effects of puberty and parental adiposity. There 
were, however, limitations. This was a cross-sectional design, and a comparison of children in 
T1-3 and T4-5 in longitudinal studies would be required to predict the effect of puberty in 
individual subjects. Furthermore, pubertal status and parental anthropometry (height, 
weight, and waist measurements) were self-reported by participants. Self-reported height 
tends to be overestimated and weight underestimated,18 leading to an underestimation of 
obesity prevalence and an exaggeration of the relationship with cardiovascular disease risk.25 
We used the protocol developed by Taylor et al.19 to estimated pubertal development. It 
should also be noted that children tend to underestimate pubertal development when using 
these line drawings.19 
Sex hormones influence adipocyte deposition and function,26 and adolescence has 
been considered a critical time in the development of obesity.27,28 However, while there is a 
relationship between obesity and the early onset of puberty in girls, the data for boys are 
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inconclusive.29 There is also insufficient evidence that puberty is causally linked to obesity 
development. In a large cross-sectional study, sexual dimorphism in fat patterning was 
present pre-puberty and increased across puberty, with girls having less waist fat.28 The trend 
in British adolescents over recent decades for having increases in waist circumference exceed 
increases in BMI, particularly in girls, suggests that abdominal fatness is increasing at a greater 
rate than whole-body fatness.30 In our study, despite having triceps SKF that was lower, boys 
had similar WHtR compared to girls. This observation could be explained by a relatively 
greater contribution of visceral fat to the abdominal measurement in boys.31 Assessing the 
value of using WHtR and SKF measurements (triceps and trunk-to-extremity ratios) to track 
adiposity across puberty would require longitudinal studies with larger cohorts. 
We identified gender differences in circulating concentrations of biomarkers that are 
associated with cardiovascular disease. Fasting insulin and triglyceride concentrations were 
higher in girls than in boys. In boys with higher WHtR, there was an inverse relationship 
between cardiovascular fitness and insulin levels. It is now recognized that cardiorespiratory 
fitness influences the relationship between adiposity and cardiovascular prognosis.4,32 In 
boys, fat mass accrual during emerging adulthood is mitigated by physical activity.33 It 
therefore could be speculated that encouraging physical fitness in this group might have a 
significant impact in reducing cardiometabolic risk. Higher hsCRP levels were observed in 
boys, which is consistent with a previous study of obese adolescents.14 In contrast, in pre-
pubertal children CRP is reported to be higher in girls34 and adult women independent of 
exogenous oestrogen.35 In adults, there is a strong inverse relationship between hsCRP levels 
and adiposity, and these independently predict cardiovascular disease events.36 Although CRP 
levels in children predict values in adults37 and predict adult obesity,38 evidence that CRP in 
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children is a predictor of cardiovascular risk in adulthood is not strong.39 In obese girls, high 
hsCRP concentrations are associated with insulin resistance.33 In our study, although hsCRP 
correlated with WHtR in boys and girls, there was no relationship to fasting insulin. In linear 
regression analysis, there was an influence of WHtR on hsCRP concentrations that is 
independent of the ratio of trunk-to-extremity SKF. HMW-adiponectin, which has both anti-
inflammatory and insulin-sensitising properties, is reported to be inversely related to 
adiposity and insulin resistance.36 These relationships were not present in our study. 
However, we did observe that concentrations were lower in boys, particularly in the late 
puberty group, which may be explained by a direct effect of testosterone on adipocyte 
production.40 Lower adiponectin concentrations, taken together with relatively greater waist 
circumference measurements and higher CRP levels, suggest that adolescent boys have more 
visceral adiposity and associated systemic inflammation. 
It has been suggested that a WHtR above 0.5 in children should be used to predict 
health risk when those children become adults.41 A study of Australian children aged 8-16 
years showed that a WHtR of ≥0.46 for boys and ≥0.45 for girls identified those with 
percentage body fat ≥85th percentile.42 In black South African adolescents a lower WHtR 
cutoff of 0.41 indicated metabolic risk.43 In our study, adolescents with a WHtR above 0.44 
had higher levels of cardiovascular biomarkers. It has been suggested that WHtR further 
specifies cardiometabolic risk within classifications that are based on BMI percentiles.44 We 
observed that parental BMI measurements were also higher in those with a WHtR above 0.44. 
While this may indicate that childhood overweight and obesity is strongly related to the social 
environment, genetic factors may also play a role.45 Birth weight is reported to predict later 
obesity.46 In our study, the child’s birth weight reported by the parents was associated with 
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height in girls; however, an association with markers of adiposity was not observed, 
suggesting that birth weight may not be a consistent predictor of later overweight and 
obesity.  
In our group of 12-year olds, pubertal status had no impact on the level of physical 
fitness in girls or boys. In a recent longitudinal study of younger children, persistently low, or 
a decline in, cardiorespiratory fitness was associated with later cardiovascular disease risk.47 
Although cardiovascular fitness was not related to parental BMI in our study, the observation 
that parental overweight and obesity is associated with higher waist measurements in 
children suggests that strategies for reducing cardiovascular risk should be family focused.  
5. Conclusion 
In adolescents, there is a relationship between measures of adiposity and parental weight 
that involves factors other than cardiovascular fitness. Adolescent boys have relatively more 
abdominal fat than girls and tend to have a proinflammatory profile of biomarkers. These 
observations suggest that family and social environmental interventions to prevent obesity 
are best undertaken early in childhood, particularly in boys. 
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Table 1 Stage of puberty in girls (A) and boys (B) – children’s estimates of pubertal stages 
using line drawings described in Methods. (Taylor et al., 2001)18 based on Tanner (1962)19 
 
 
          Girls (Breast)                Boys (Genitalia)     
Pubic hair 1 2 3 4 5 Total 1 2 3 4 5 Total 
1 0 0 0 0 0 0 0 0 0 0 0 0 
2 1 8 8 1 0 18 1 5 9 2 2 19 
3 1 6 29 10 8 44 0 3 12 9 0 24 
4 0 3 14 20 9 46 1 1 9 27 7 45 
5 0 0 3 5 3 11 0 0 1 3 3 7 
Total 2 17 54 36 20 129 2 9 31 41 12 95 
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Table 2Gender differences in markers of metabolic and cardiovascular risk in adolescent children (mean ± SD (95%CI) 
 Girls Boys  
 mean (SD; 95% CI) (n = 129) 
mean (SD; 95% CI) 
(n = 95) p value
a 
        Age (years) 13.48 ± 0.30 (13.43-13.53) 13.53 ±0.33(13.46-13.60) 0.231 
        Anthropometry    
height (cm)  158.1 ±6.7 (156.9-159.3) 160.1 ±9.0(158.3-161.9) 0.056 
waist (cm)b 65.2 ±1.1(63.9-66.6) 67.7 ±1.1(66.0-69.5) 0.023 
weight (kg)  53.3 ±11.0(51.4-55.2) 53.2 ±13.1(50.5-55.8) 0.921 
WHtR (%)b 41.3 ±1.1(40.5-42.1) 42.4 ±1.1(41.4-43.4) 0.088 
birth weight (kg) 3.33 ±0.36(3.23-3.43) 3.52 ±0.59(3.40-3.64)g 0.017 
subscapular SKF (mm)b 10.8 ±1.6(10.0-11.7) 8.8 ±1.7(7.9-9.8) <0.001 
suprailiac SKF (mm)b 12.2 ±1.6(11.3-13.3) 9.1 ±1.9(8.0-10.4) <0.001 
triceps SKF (mm)b 16.1 ±1.4(15.1-17.2) 12.7 ±1.6(11.6-13.9) <0.001 
biceps SKF (mm)b 10.2 ±1.5(9.5-11.0) 7.9 ±1.6(7.1-8.7) 0.001 
4SKF (mm)b,c 50.2 ±1.5(47.1-53.6) 39.2 ±1.6(35.4-43.4) <0.001 
T/E SKFb,d 0.87 ±1.3(0.84-0.91) 0.87 ±1.36(0.82-0.93) 0.915 
        Blood pressure    
Systolic (mmHg) 115.6 ±10.1 (113.8-117.3) 116.8 ±12.6(114.2-119.3) 0.422 
Diastolic (mmHg) 65.7 ±10.2(63.9-67.5) 64.7 ±11.0(62.4-66.9) 0.472 
 
       Cardiovascular fitness (laps) 
 
44.5 ±1.4(41.9-47.2) 
 
62.6 ±1.4(58.4-67.0) 
 
<0.001 
  
       Biomarkers    
Total cholesterol (mmol/l)b 4.01 ±1.15(3.90-4.12) 3.76 ±1.18(3.63-3.89) 0.003 
LDL-cholesterol (mmol/l)b 1.95 ±1.33(1.86-2.05) 1.81 ±1.35(1.70-1.92) 0.052 
HDL-cholesterol (mmol/l)b 1.67 ±1.21(1.62-1.73) 1.60 ±1.24(1.53-1.67) 0.114 
Triglyeride (mmol/l)b 0.71 ±1.43(0.66-0.75) 0.59 ±1.53(0.54-0.64) <0.001 
Glucose (mmol/l)b 4.80 ±0.27(4.75-4.85)g 4.92 ±0.35(4.85-4.99)f 0.006 
Insulin (mIU/l)b 10.02 ±1.47(9.37-10.71) 6.96 ±1.58(6.34-7.63) <0.001 
HOMA (insulin*glucose/22.5)b 2.16 ±1.49(2.01-2.32)g 1.53 ±1.63(1.38-1.69)f <0.001 
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Fibrinogen (g/l)b 2.62 ±1.19(2.54-2.70)e 2.63 ±1.18(2.54-2.73)e 0.807 
hsCRP (mg/l)b 0.29 ±2.19(0.26-0.34)f 0.43 ±2.38(0.36-0.52) <0.001 
IL-6 (ng/l)b 0.57 ±2.09(0.50-0.64)f 0.69 ±2.14(0.59-0.81)e 0.047 
HMW-Adiponectin (mg/l)b 2.93 ±1.77(2.65-3.24)f 2.11 ±1.89(1.85-2.40)e <0.001 
    
Notes:aUnpaired t test girls vs. boys Bonferroni-corrected α=0.002; bgeometric mean ± SD; csum of triceps, subscapular, biceps, and suprailiac SKF; dratio of trunk (sum of 
subscapular and suprailiac)-to-extremity (sum of triceps and biceps) SKF; edata missing from 1 participant, fdata missing from 2 participants, gdata missing from 3 participants 
Abbreviations: WHtR = Waist-to-height ratio; SKF = Skinfold-thickness; T/E SKF= the ratio of trunk-to-extremity skinfold thicknessesSKF; LDL = Low density lipoprotein; HDL = 
high-density lipoprotein; HOMA = homeostatic model assessment. 
HsCRP = High-sensitivity C-reactive protein; HMW = High Molecular Weight; IL-6 = Interleukin 6. 
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Table 3 Gradient b (SE) derived from log-log relationship between height and SKF in children who reported being in stage 1-3 (T1-3) and in stage 
4-5(T4-5 ) for breast development in girls and genital development in boys, using line drawings (Taylor et al., 2001)18 based on Tanner (1962)19 
 
 Girls  Boys 
Pubertal stage T1-3, n=73 T4-5, n=56  T1-3, n=42 T4-5, n=53 
Age, mean (SD, 95%CI) 13.4 ±0.30, 13.4-13.5) 13.6 ±0.29, 13.5-13.6) #  13.5 ±0.36, 13.4-13.6) 13.6 ±0.30, 13.5-13.7) 
4SKFa 2.14 (0.93) 0.70 (1.34)  4.66 (1.19)*** -1.28 (0.26) 
Triceps 1.77 (0.92) 0.11 (1.28)  2.73 (1.08) -2.23 (1.19) 
Biceps 0.49 (0.99) 0.51 (1.59)  3.53 (1.14)** -2.26 (1.36) 
Subscapular 2.84 (1.08)* 0.27 (1.67)  6.05 (1.27)*** 0.18 (1.21) 
Suprailiac 3.51 (1.15)** 2.11 (1.61)  6.66 (1.59)*** -0.43 (1.66) 
T/E SKFb 1.91 (0.58)** 1.10 (0.93)  3.37 (0.64)*** 2.08 (0.75)** 
a, sum of four SKFs 
b, trunk-to-extremity SKF ratio ((subscapular+suprailiac)/triceps+biceps)) 
Bonferroni-corrected α=0.01; significant results in bold italics. *, p≤0.01; **, p≤0.005; ***, p≤0.001 significant relationship between height and 4SKF in children in T1-3 for 
girls and for boys; #, p=0.016, compared to girls in T1-3 (independent t test) 
Abbreviations: CI = confidence interval; SKF = Skinfold-thickness; T/E SKF= the ratio of trunk-to-extremity skinfold thicknessesSKF;   
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Table 4 Characteristics of children with waist measurements that were >44% height(mean(95%CI)).  
WHtR (%) > 44% > 44% ≤ 44% ≤ 44%    
Sex Girls Boys Girls Boys p valuea 
n (% own gender group) 35 (27%) 26 (27%) 94 (73%) 69 (73%) Waist Sex Interaction 
     Anthropometry        
height (cm)  159.3 (157.1-161.5) 160.4 (156.3-164.5) 157.7 (156.3-159.1) 160.0 (157.9-162.1) 0.393 0.145 0.598 
WHtR (%)b 47.8 (46.8-49.0) 49.4 (47.9-50.9) 39.1 (38.7-39.5) 40.0 (39.4-40.6) <0.001 0.003 0.584 
4SKFb,c 78.5 (72.7-84.7) 71.4 (60.2-84.7) 42.6 (40.3-45.0) 31.3 (29.1-33.6) <0.001 <0.001 0.017 
T/E SKFb,d 1.06 (0.98-1.15) 1.02 (0.90-1.17) 0.81 (0.77-0.85) 0.82 (0.76-0.87) <0.001 0.741 0.644 
triceps SKFb 23.3 (21.1-25.7) 20.7 (19.0-23.7) 14.0 (13.3-14.9) 10.6 (9.7-11.4) <0.001 <0.001 0.078 
weight (kg) 66.4 (63.2-69.5) 65.7 (59.3-72.2) 48.5 (47.1-49.8) 48.4 (46.5-50.3) <0.001 0.803 0.824 
birth weight 3.37 (3.14-3.60) 3.46 (3.19-3.73)e 3.31 (3.20-3.43) 3.54 (3.40-3.68)e 0.613 0.044 0.976 
     Blood pressure        
Systolic (mmHg) 117.3 (114.7-120.0) 117.5 (111.2-123.9) 114.9 (112.7-117.1) 116.5 (113.8-119.2) 0.307 0.599 0.681 
Diastolic (mmHg) 70.5 (67.4-73.6) 68.3 (63.0-73.7) 63.9 (61.9-66.0) 63.3 (61.0-65.6) <0.001 0.375 0.629 
     Cardiovascular fitness (laps) 35.3 (31.3-39.2) 52.8 (44.6-61.0) 51.4 (48.4-54.5) 70.7 (66.5-74.9) <0.001 <0.001 0.711 
     Biomarkers        
total cholesterol (mmol/l)b 3.97 (3.75-4.21) 3.69 (3.43-3.98) 4.02 (3.90-4.15) 3.78 (3.64-3.93) 0.468 0.006 0.809 
LDL-cholesterol (mmol/l)b 2.05 (1.86-2.27) 1.81 (1.58-2.06) 1.92 (1.81-2.03) 1.81 (1.68-1.94) 0.449 0.039 0.454 
HDL-cholesterol (mmol/l)b 1.52 (1.43-1.62) 1.49 (1.37-1.62) 1.73 (1.67-1.80) 1.64 (1.56-1.73) <0.001 0.223 0.627 
triglyeride (mmol/l)b 0.76 (0.66-0.87) 0.67 (0.56-0.81) 0.69 (0.64-0.73) 0.56 (0.50-0.61) 0.012 0.005 0.410 
glucose (mmol/l)b,f 4.81 (4.72-4.90) 4.89 (4.76-5.01) 4.80 (4.74-4.85) 4.93 (4.84-5.01) 0.783 0.027 0.569 
Insulin (mIU/l)b 11.4 (10.1-12.9) 8.7 (7.0-10.7) 9.5 (8.8-10.3) 6.4 (5.8-7.1) <0.001 <0.001 0.314 
HOMA (insulin*glucose/22.5) b,f 2.50 (2.20-2.84) 1.93 (1.53-2.42) 1.97 (1.78-2.20) 1.37 (1.21-1.55) <0.001 <0.001 0.482 
fibrinogen (g/l)b,h 3.04 (2.86-3.23) 2.96 (2.82-3.12) 2.48 (2.41-2.55,93) 2.52 (2.42-2.62,68) <0.001 0.848 0.355 
hsCRP (mg/l)b 0.62 (0.45-0.85,33) 0.74 (0.54-1.03) 0.23 (0.20-0.25) 0.35 (0.29-0.43) <0.001 0.005 0.240 
IL-6 (ng/l)b,g 0.78 (0.63-0.95) 0.76 (0.55-1.04,25) 0.50 (0.43-0.59,92) 0.67 (0.56-0.81) 0.016 0.241 0.157 
HMW-Adiponectin(mg/l)b,g 2.75 (2.25-3.37) 1.88 (1.41-2.51,25) 3.00 (2.67-3.38,92) 2.19 (1.89-2.54) 0.188 <0.001 0.707 
     Parental data (CI; n)        
Maternal BMI (kg/m2) 28.8 (26.7-30.9; 33) 28.3 (26.5-30.0; 26) 25.6 (24.6-26.5; 85) 26.1 (25.1-27.2; 65) 0.001 0.677 0.231 
Maternal waist2/htx10b 4.37 (3.91-4.89; 29) 4.31 (3.82-4.85; 24) 3.78 (3.55-4.03; 79) 3.75 (3.51-4.01; 63) 0.001 0.774 0.838 
Paternal BMI (kg/m2) 28.6 (26.9-30.3; 28) 30.6 (28.7-32.5; 22) 27.4 (26.5-28.2; 81) 27.8 (26.7-28.7; 66) 0.004 0.094 0.225 
Paternal waist2/htx10b 4.61 (4.34-4.90; 27) 5.02 (4.59-5.49; 21) 4.48 (4.33-4.65; 78) 4.63 (4.45-4.82; 66) 0.070 0.033 0.293 
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a2-way ANOVA, Bonferroni-corrected α=0.002; bgeometric mean; csum of triceps, subscapular, biceps and suprailiac SKF; dratio of trunk (sum of subscapular and suprailiac)-
to-extremity (sum of triceps and biceps) SKF; edata missing for 1 individual; fdata missing for 3 girls ≤ 44% and 2 boys ≤ 44%; gdata missing for 1 boy > 44%, 2 girls ≤ 44%; hdata 
for 1 girl ≤ 44% and 1 boy ≤ 44%  
Abbevations: SKF = Skinfold-thickness; LDL = Low density lipoprotein; HDL = high-density lipoprotein; HOMA = homeostatic model assessment  
• hsCRP = High-sensitivity C-reactive protein; HMW = High Molecular Weight; BMI = Body Mass Index. 
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Table 5 Correlations between anthropometric variables in parents and children (Pearson’s r) 
 
 Girls (n = 93) Boys (n = 80) 
 
Height BMI 
WHtR 
(%)a 
T/E 
SKFa 
Triceps 
SKFa 
Height BMI 
WHtR 
(%)a 
T/E 
SKFa 
Triceps 
SKFa 
Child BMI 0.196 — — — — .0304** — — — — 
Child WHtR (%)a -0.023 0.897*** — — — -0.002 0.881*** — — — 
Child T/E SKFa 0.268** 0.509*** 0.497*** — — 0.454*** 0.573*** 0.433** — — 
Child Triceps SKFa  0.133 0.748*** 0.700*** 0.125 — 0.019 0.764*** 0.797*** 0.076 — 
Maternal height 0.359*** -0.029 -0.050 0.151 -0.075 0.337** 0.132 0.056 -0.079 0.209 
Paternal height 0.297** 0.004 -0.042 -0.063 0.111 0.145 0.068 0.034 0.012 0.182 
Midparental heightb 0.423*** -0.014 -0.060 0.044 0.035 0.324** 0.134 0.060 -0.047 0.259* 
Maternal BMI 0.094 0.351** 0.324** 0.172 0.350*** 0.181 0.286** 0.225* 0.129 0.279* 
Paternal BMI -0.160 0.215* 0.204* 0.291** 0.011 0.066 0.315** 0.263* 0.254* 0.133 
Maternal W2HtRa 0.123 0.189 0.199 0.201 0.211* 0.271* 0.307** 0.261* 0.236* 0.301** 
Paternal W2HtRa -0.087 0.068 0.108 0.198 -0.065 0.070 0.210 0.198 0.192 0.120 
a, log-transformed 
b, for girls = (father’s height - 13cm. + mother’s height)/2; for boys = (mother’s height + 13cm. + father’s height)/2 
*, p≤0.05; **, p≤0.01; ***, p≤0.001; Bonferroni-corrected α = 0.004, significant results in bold italicsAbbevations: BMI =  Body Mass Index; SKF = Skinfold-
thickness; T/E = trunk-to-extremity.
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Fig. 1 Relationship between WHtR and triceps skinfold thickness (SKF; A, C) or the ratio of trunk-to-
extremity  (T/E) SKF (B, D), in girls (A, C) and boys (B, D). The open symbols represent those self-reporting 
being in Tanner stages 1-3 for breast development in girls and genital development in boys. The closed 
symbols represent Tanner stages 4-5. 
Non-linear regression lines and correlations for the relationships indicated by the solid lines: 
(A) lnWHtR=4.264-0.601*lnTricepsSKF+0.144*lnTricepsSKF2, r2=0.538, p<0.001 (129 girls) 
(B) lnWHtR=3.738+0.294*lnT/E SKF+0.298*lnT/ESKF2, r2=0.308, p<0.001 (129 girls) 
(C) lnWHtR=3.842-0.287*lnTricepsSKF+0.095*lnTricepsSKF2, r2=0.690, p<0.001 (95 boys) 
(D) lnWHtR=3.746+0.247*lnT/ESKF+0.308*lnT/ESKF2, r2=0.271, p<0.001 (95 boys) 
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Figure 2 
Relationship between WHtR (%) and other markers of metabolic and cardiovascular risk in adolescent girls 
(closed symbols, intact line) and boys (open symbols, broken line). 
Linear regression lines and correlations for the relationships: 
(a) lnInsulin = 1.041*lnWHtR-1.568;  r= 0.288, p < 0.001 (129 girls) and lnInsulin = 1.572*lnWHtR-3.949; 
r = 0.394, p < 0.001 (95 boys) 
(b) lnFibrinogen = 0.948*lnWHtR-2.565; r = 0.585, p < 0.001 (128 girls) and lnFibrinogen = 
0.702*lnWHtR-1.662; r = 0.477, p < 0.001 (94 boys) 
(c) lnTriglyceride = 0.771*lnWHtR-3.219; r = 0.226, p = 0.010 (129 girls) and lnTriglyceride = 
1.186*lnWHtR-4.977;  r= 0.322, p = 0.002 (95 boys) 
(d) lnHDL = 3.309-0.751*lnWHtR;  r= -0.411, p < 0.001 (129 girls) and lnHDL = 2.407-0.517*lnWHtR; r = 
-0.273, p = 0.008 (95 boys) 
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(e) lnCRP = 4.14*lnWHtR-16.62; r = 0.553, p < 0.001 (127 girls) and lnCRP = 3.46*lnWHtR-13.80; r=0.456, 
p < 0.001 (95 boys) 
(f) diastolic BP=24.29*lnWHtR-24.66; r=0.252, p = 0.004 (129 girls) and diastolic BP = 31.80*lnWHtR-
54.46; r = 0.330, p < 0.001 (95 boys) 
DBP = diastolic blood pressure; HDL = high-density lipoprotein; hsCRP = High-sensitivity C-reactive 
protein 
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